| 產品名稱 | Saccharomyces cerevisiae Meyen ex E.C. Hansen |
|---|---|
| 商品貨號 | B180530 |
| Deposited As | Saccharomyces cerevisiae Hansen, teleomorph |
| Classification | Saccharomycetes, Saccharomycetidae, Saccharomycetales, Saccharomycetaceae, Saccharomycetaceae, Saccharomyces, cerevisiae |
| Strain Designations | SWY459 |
| Alternate State | Candida robusta Diddens et Lodder |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format | frozen |
| Type Strain | no |
| Genotype | MATalpha ura3-1 his3-11 his3-15 trp1-1 leu2-3 leu2-112 can1-100 ade2-1:ADE2-URA3
Ref  Bucci M, Wente SR. A novel fluorescence-based genetic strategy identifies mutants of Saccharomyces cerevisiae defective for nuclear pore complex assembly. Mol. Biol. Cell 9: 2439-2461, 1998. PubMed: 9725905 |
| Preceptrol® | no |
| Mating Type | alpha |
| Ploidy | haploid |
| Medium | ATCC® Medium 1245: YEPD |
| Growth Conditions | Temperature: 25.0°C |
| Name of Depositor | M Bucci |
| Special Collection | NCRR Contract |
| References | Bucci M, Wente SR. A novel fluorescence-based genetic strategy identifies mutants of Saccharomyces cerevisiae defective for nuclear pore complex assembly. Mol. Biol. Cell 9: 2439-2461, 1998. PubMed: 9725905 Bucci M, Wente SR. A novel fluorescence-based genetic strategy identifies mutants of Saccharomyces cerevisiae defective for nuclear pore complex assembly. Mol. Biol. Cell 9: 2439-2461, 1998. PubMed: 9725905 |
| 梅經理 | 17280875617 | 1438578920 |
| 胡經理 | 13345964880 | 2438244627 |
| 周經理 | 17757487661 | 1296385441 |
| 于經理 | 18067160830 | 2088210172 |
| 沈經理 | 19548299266 | 2662369050 |
| 李經理 | 13626845108 | 972239479 |
